TOMM20 and Alzheimer disease: In this context, the downregulation of TOM20 might be exerting a protective role by limiting the buildup of Aβ into the brain mitochondria under pathological AD-like conditions, thus paving the way for the use of MWCNTs as possible therapeutic agents to counteract this age-related neurodegenerative disorder.